Sign Up to like & get
recommendations!
1
Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_79
Abstract: GCB and 34 CD5(+)/CD10(‐) non‐GCB DLBCL. Karyotype was successfully assessed in 43%, BCL2, BCL6, MYC abnormalities were found in 65%, 30%, and 26% in CD5(+)/CD10(+), and in 66%, 70%, and 23% in CD5(+)/CD10(‐), respectively, of…
read more here.
Keywords:
cd5;
cd5 cd10;
cd5 dlbcl;
response ... See more keywords